All terms in MESH
| Label | Id | Description |
|---|---|---|
| 7,10-dihydro-7-oxoimidazo(4,5,1-ij)pyrrolo(2,3-f)quinoline-1,3,9-tricarboxylic acid | C104140 | |
| RASL10A protein, human | C104142 | |
| 2-(4-methoxyphenyl)-5,6-trimethylene-4H-1,3,2-oxathiaphosphorine-2-sulfide | C000605410 | |
| Allomyces | D055134 | [A genus of aquatic fungi in the phylum BLASTOCLADIOMYCOTA. It is abundant in warmer climates and exhibits true alternation of generations.] |
| RWJ 50215 | C104134 | |
| N-(dicyclohexylcarbamoylmethyl)-N-(3-diethylaminopropyl)-4-nitrobenzamide hydrochloride | C104135 | |
| uridine diphosphate galactofuranose | C104136 | |
| 3-nitroacetanilide | C104137 | |
| ONO 9902 | C104138 | |
| 2-(4-(3-methyl-2-thienyl)phenyl)propionic acid | C104139 | |
| poly(caprolactone-co-6-methyl-2,5-morpholinedione) | C118770 | |
| N(1)-ethyl-N-(11)-((cycloheptyl)methyl)-4,8-diazaundecane | C118771 | |
| N(1)-ethyl-N-(11)-(2-methyl-1-butyl)-4,8-diazaundecane | C118772 | |
| AT 3510 | C118773 | |
| Gelucire 55-18 | C118752 | |
| SEMA7A protein, human | C118753 | |
| Hypodermoclysis | D055103 | [Technique for treating DEHYDRATION and WATER-ELECTROLYTE IMBALANCE by subcutaneous infusion of REHYDRATION SOLUTIONS.] |
| Fluid Therapy | D005440 | [Therapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to WATER-ELECTROLYTE BALANCE. Fluids may be administered intravenously, orally, by intermittent gavage, or by HYPODERMOCLYSIS.] |
| Infusions, Subcutaneous | D055104 | [The administration of liquid medication or nutrients under the skin, usually over minutes or hours.] |
| Infusions, Parenteral | D007263 | [The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping.] |